Novo Holdings F Star Therapeutics, Inc. Transaction History

Novo Holdings

  • $1.43 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.71 - $7.38 $12,731 - $19,948
-2,703 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$6.57 - $10.71 $211,002 - $343,962
-32,116 Reduced 92.24%
2,703 $23,000
Q4 2020

Feb 16, 2021
BUY
$1.03 - $10.39 $35,863 - $361,769
34,819 New
34,819 $344,000

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email